本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

73.59
+1.482.05%
盤後73.590.00000.00%19:30 EDT
成交量:43.16萬
成交額:3,163.06萬
市值:16.90億
市盈率:16.21
高:73.86
開:72.21
低:72.21
收:72.11
52周最高:99.39
52周最低:69.58
股本:2,297.04萬
流通股本:2,028.20萬
量比:1.25
換手率:2.13%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
淨資產收益率:20.46%
總資產收益率:5.45%
市淨率:2.83
市盈率(LYR):22.17

資料載入中...

2026/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

重要事件披露

Form 8-K - Current report
2026/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/07

重要事件披露

Form 8-K - Current report